Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting and preventing sudden death from cardiac causes

J K Gilman1, S Jalal, G V Naccarelli

  • 1Cardiology Service, Brooke Army Medical Center, Fort Sam Houston, Tex.

Circulation
|August 1, 1994
PubMed
Summary

Sudden cardiac death, often from ventricular tachyarrhythmia, has low survival rates. Aggressive screening and treatment, including implantable cardioverter-defibrillators, are crucial for high-risk patients to improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influences for Gender Disparity in Academic Neuroradiology.

AJNR. American journal of neuroradiology·2017
Same author

Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.

Indian journal of nephrology·2010
Same author

Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2009
Same author

Asymptomatic Paget's disease of bone presenting with complete atrioventricular block.

Chinese medical journal·2008
Same author

Constrictive pericarditis presenting as recurrent ascites for 10 years.

Saudi medical journal·2007
Same author

Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Sudden cardiac death (SCD) is frequently caused by ventricular tachyarrhythmias.
  • Survival rates for out-of-hospital cardiac arrest remain low (around 20%).
  • Current risk stratification for post-myocardial infarction (MI) patients has limited predictive value.

Purpose of the Study:

  • To review current strategies for risk stratification and treatment of patients at high risk for sudden cardiac death.
  • To evaluate the effectiveness of antiarrhythmic drugs and implantable cardioverter-defibrillators (ICDs) in preventing SCD.
  • To highlight ongoing research and trials defining optimal management for lethal ventricular arrhythmias.

Main Methods:

  • Review of existing literature on sudden cardiac death, ventricular arrhythmias, and post-MI risk stratification.

Related Experiment Videos

  • Analysis of the efficacy of beta-blockers and amiodarone in reducing mortality.
  • Discussion of ongoing clinical trials, including the Antiarrhythmic Drug versus Implantable Device (AVID) trial.

    • Main Results:

    • Implantable cardioverter-defibrillators (ICDs) show superiority over antiarrhythmic drugs in reducing SCD incidence.
    • Total mortality may not be significantly altered by ICDs compared to antiarrhythmic drugs.
    • Sotalol and amiodarone appear most effective in preventing recurrence of sustained ventricular tachyarrhythmias.

    Conclusions:

    • Aggressive treatment and screening are mandatory to improve survival rates in high-risk cardiac patients.
    • While ICDs reduce SCD, their impact on overall mortality requires further investigation.
    • Ongoing trials are essential to establish the best therapeutic strategies for preventing sudden cardiac death.